US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510
SINGAPORE--(BUSINESS WIRE)--#CancerTreatment--Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea,…